Bifogade filer
Kurs & Likviditet
Kalender
2023-02-22 | Bokslutskommuniké 2022 |
2022-12-05 | Extra Bolagsstämma 2022 |
2022-07-21 | Kvartalsrapport 2022-Q2 |
2022-05-31 | Årsstämma 2022 |
2022-05-06 | Ordinarie utdelning KARO 0.00 SEK |
2022-02-25 | Bokslutskommuniké 2021 |
2021-10-28 | Kvartalsrapport 2021-Q3 |
2021-07-22 | Kvartalsrapport 2021-Q2 |
2021-04-23 | Ordinarie utdelning KARO 0.00 SEK |
2021-04-21 | Kvartalsrapport 2021-Q1 |
2021-04-21 | Årsstämma 2021 |
2021-02-18 | Bokslutskommuniké 2020 |
2020-10-30 | Kvartalsrapport 2020-Q3 |
2020-07-21 | Kvartalsrapport 2020-Q2 |
2020-05-25 | Årsstämma 2020 |
2020-04-30 | Ordinarie utdelning KARO 0.00 SEK |
2020-04-29 | Kvartalsrapport 2020-Q1 |
2020-02-20 | Bokslutskommuniké 2019 |
2019-11-15 | Kvartalsrapport 2019-Q3 |
2019-09-20 | Extra Bolagsstämma 2019 |
2019-07-19 | Kvartalsrapport 2019-Q2 |
2019-05-17 | Ordinarie utdelning KARO 0.00 SEK |
2019-05-16 | Årsstämma 2019 |
2019-04-26 | Kvartalsrapport 2019-Q1 |
2019-02-14 | Bokslutskommuniké 2018 |
2018-11-01 | Kvartalsrapport 2018-Q3 |
2018-07-19 | Kvartalsrapport 2018-Q2 |
2018-05-04 | Ordinarie utdelning KARO 0.30 SEK |
2018-05-03 | Årsstämma 2018 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-02-22 | Bokslutskommuniké 2017 |
2017-12-08 | Extra Bolagsstämma 2017 |
2017-11-02 | Kvartalsrapport 2017-Q3 |
2017-08-24 | Kvartalsrapport 2017-Q2 |
2017-05-12 | Ordinarie utdelning KARO 0.28 SEK |
2017-05-12 | Bonusutdelning KARO 0.22 |
2017-05-11 | Årsstämma 2017 |
2017-05-10 | Kvartalsrapport 2017-Q1 |
2017-02-28 | Bokslutskommuniké 2016 |
2016-10-27 | Kvartalsrapport 2016-Q3 |
2016-07-15 | Kvartalsrapport 2016-Q2 |
2016-05-13 | Ordinarie utdelning KARO 0.00 SEK |
2016-05-12 | Kvartalsrapport 2016-Q1 |
2016-05-12 | Årsstämma 2016 |
2016-03-16 | Extra Bolagsstämma 2016 |
2016-02-12 | Bokslutskommuniké 2015 |
2015-10-29 | Kvartalsrapport 2015-Q3 |
2015-08-26 | Split KARO 20:1 |
2015-07-10 | Kvartalsrapport 2015-Q2 |
2015-04-30 | Ordinarie utdelning KARO 0.00 SEK |
2015-04-29 | Årsstämma 2015 |
2015-04-29 | Kvartalsrapport 2015-Q1 |
2015-02-13 | Bokslutskommuniké 2014 |
2014-10-29 | Kvartalsrapport 2014-Q3 |
2014-07-11 | Kvartalsrapport 2014-Q2 |
2014-05-09 | Ordinarie utdelning KARO 0.00 SEK |
2014-05-08 | Årsstämma 2014 |
2014-05-08 | Kvartalsrapport 2014-Q1 |
2014-03-17 | Extra Bolagsstämma 2014 |
2014-02-13 | Bokslutskommuniké 2013 |
2013-10-25 | Kvartalsrapport 2013-Q3 |
2013-07-12 | Kvartalsrapport 2013-Q2 |
2013-05-08 | Ordinarie utdelning KARO 0.00 SEK |
2013-05-07 | Kvartalsrapport 2013-Q1 |
2013-05-07 | Årsstämma 2013 |
2013-03-13 | 15-7 2013 |
2013-02-12 | Bokslutskommuniké 2012 |
2013-02-12 | Analytiker möte 2013 |
2012-11-19 | Extra Bolagsstämma 2012 |
2012-10-24 | Kvartalsrapport 2012-Q3 |
2012-07-13 | Kvartalsrapport 2012-Q2 |
2012-06-12 | Årsstämma 2012 |
2012-04-30 | Ordinarie utdelning KARO 0.00 SEK |
2012-04-27 | Kvartalsrapport 2012-Q1 |
2012-02-08 | Bokslutskommuniké 2011 |
2011-11-29 | 15-7 2011 |
2011-10-25 | Kvartalsrapport 2011-Q3 |
2011-07-13 | Kvartalsrapport 2011-Q2 |
2011-04-28 | Ordinarie utdelning KARO 0.00 SEK |
2011-04-27 | Årsstämma 2011 |
2011-04-27 | Kvartalsrapport 2011-Q1 |
2011-02-09 | Bokslutskommuniké 2010 |
2010-10-26 | Kvartalsrapport 2010-Q3 |
2010-07-13 | Kvartalsrapport 2010-Q2 |
2010-04-26 | Ordinarie utdelning KARO 0.00 SEK |
2010-04-23 | Årsstämma 2010 |
2010-04-22 | Kvartalsrapport 2010-Q1 |
2010-02-09 | Bokslutskommuniké 2009 |
2009-10-22 | Kvartalsrapport 2009-Q3 |
2009-07-14 | Kvartalsrapport 2009-Q2 |
2009-04-27 | Ordinarie utdelning KARO 0.00 SEK |
2009-04-24 | Årsstämma 1 |
2009-04-22 | Kvartalsrapport 2009-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Under the the authorization from the 2021 Annual General Meeting, the Board of Directors has resolved to sell up to 1,768,000 own shares to expand the company's financial flexibility. The sale of own shares shall be effected - on one or several occasions before the 2022 Annual General Meeting, where a new mandate should be requested if necessary - on Nasdaq Stockholm at a price within the effective registered price interval on Nasdaq Stockholm, such interval being the interval between the highest purchase price and the lowest sales price. The transfers shall be executed in accordance with Section 5.1.1 part H of the Nasdaq Issuer Rules and otherwise in accordance with all applicable rules and regulation.
For information on the transaction of own shares, please see www.nasdaqomxnordic.com. Transactions of own shares will not be press released separately, unless mandatory disclosure obligations apply.
The total number of holdings of own shares in Karo Pharma at the time of this press release was 1,768,000 and the total number of shares in issue was 225,033,204. Consequently, the company's total holdings of own shares represent 0.79% of the total number of shares.
For further information, please contact:
Christoffer Lorenzen, CEO, +4673-501 76 20, christoffer.lorenzen@karopharma.com
Jon Johnsson, CFO, 073-507 88 61, jon.johnsson@karopharma.com
About Karo Pharma
Karo Pharma delivers smart choices for everyday healthcare. We own and commercialize branded, original over-the-counter products and prescription medicines. Our products are available in more than 60 countries, with Europe and the Nordic region as our core markets. Karo Pharma is headquartered in Stockholm, Sweden and listed on Nasdaq Stockholm Mid Cap.